Retatrutide
Fat Loss
A triple agonist (GIP/GLP-1/Glucagon) in clinical trials showing exceptional weight loss results.
88%
Avg. Benefit Score
1
Reported Benefits
50%
Side Effect Rate
1
Dosing Patterns
People use this for
Benefit Profile
Retatrutide's fingerprint across categories
Community Interest
Report volume over 12 months
+18% YoY
52
Reports this month
42
Monthly average
500
Total reports
Reported Benefits
1 of 1Exceptional Weight Loss
Strongly PositiveReport frequency88%
1 reports
Community Reports
"Clinical trial results are insane - up to 24% body weight loss. This could be the biggest yet."
Reported Side Effects
1Moderate
Nausea, diarrhea, constipation common.
Dosing Patterns
1 SubQ
Most Popular: SubQ at Up to 12 mg
90% of community members report using this dosing protocol 1x weekly. Individual responses vary — start low and adjust based on your experience.
Commonly Stacked With
Frequently Asked
Retatrutide is a triple hormone receptor agonist in development for obesity and diabetes.
Was this helpful?